WC
TMO icon

Waterloo Capital’s Thermo Fisher Scientific TMO Stock Holding History

Waterloo Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
2,096
-237
-10% -$114K 0.06% 241
2026
Q1 		$1.15M Sell
2,333
-618
-21% -$335K 0.08% 199
2025
Q4 		$1.71M Buy
2,951
+939
+47% +$531K 0.12% 157
2025
Q3 		$976K Buy
2,012
+262
+15% +$122K 0.07% 192
2025
Q2 		$710K Sell
1,750
-501
-22% -$209K 0.06% 223
2025
Q1 		$1.12M Buy
2,251
+355
+19% +$192K 0.1% 168
2024
Q4 		$986K Sell
1,896
-382
-17% -$210K 0.1% 162
2024
Q3 		$1.41M Sell
2,278
-24
-1% -$14.2K 0.15% 142
2024
Q2 		$1.27M Sell
2,302
-73
-3% -$41.8K 0.15% 132
2024
Q1 		$1.38M Buy
2,375
+25
+1% +$14K 0.18% 118
2023
Q4 		$1.25M Buy
2,350
+1,467
+166% +$710K 0.2% 117
2023
Q3 		$447K Buy
883
+72
+9% +$38.4K 0.13% 107
2023
Q2 		$423K Sell
811
-31
-4% -$16.7K 0.12% 102
2023
Q1 		$485K Buy
+842
New +$475K 0.15% 89

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Waterloo Capital's TMO Position: Q2 2026 in Review

Waterloo Capital reduced its Thermo Fisher Scientific (TMO) stake by 10% in Q2 2026, selling an estimated $114K and leaving 2,096 shares worth $1.05M. The position accounts for 0.06% of the portfolio, ranked #241.

Waterloo Capital first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.71M in Q4 2025. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Waterloo Capital held 2,096 shares of Thermo Fisher Scientific worth $1.05M as of Q2 2026.
  • Waterloo Capital sold 237 Thermo Fisher Scientific shares in Q2 2026, an estimated $114K.
  • Thermo Fisher Scientific made up 0.06% of Waterloo Capital's portfolio in Q2 2026, its #241 holding.
  • Waterloo Capital first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
  • Waterloo Capital's Thermo Fisher Scientific position peaked at $1.71M in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.